Aegerion, QLT merging

Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) and QLT Inc. (TSX:QLT; NASDAQ:QLTI) are to merge in a stock deal to create Novelion Therapeutics Inc. The combined company would have two marketed rare disease products and one late-stage rare disease program.

Aegerion shareholders are to receive 1.0256 QLT shares for each Aegerion share. The terms value Aegerion at $43.3 million, based on 29.5 million Aegerion shares outstanding and QLT's closing price of $1.43 on Tuesday. ...